Literature DB >> 27151631

Diagnostic criteria for PCOS: Is there a need for a rethink?

Didier Dewailly1.   

Abstract

The diagnostic criteria for polycystic ovarian syndrome (PCOS) have been grouped in different classifications that have been conflicting for many years. At present, the classification of Rotterdam is the most used, but with varying frequency depending on the country and medical specialties. This classification is now >10 years old. Although its fundamental principle (two criteria required out of three) is still valid, each of its three items (oligo-anovulation (OA), hyperandrogenism (HA), and polycystic ovarian morphology (PCOM)) needs to be updated. The definition of biological HA is still unresolved. The criteria used to define OA are insufficient. The definition of PCOM proposed in 2003 is now obsolete when using the latest generation of ultrasound machines. The serum anti-Müllerian hormone (AMH) assay seems increasingly to be an excellent substitute for follicular count and is likely to emerge as the official PCOM marker. A new consensus conference is urgently needed. Copyright Â
© 2016. Published by Elsevier Ltd.

Entities:  

Keywords:  androgens; anovulation; anti-Müllerian hormone; diagnosis; polycystic ovary syndrome; ultrasound

Mesh:

Substances:

Year:  2016        PMID: 27151631     DOI: 10.1016/j.bpobgyn.2016.03.009

Source DB:  PubMed          Journal:  Best Pract Res Clin Obstet Gynaecol        ISSN: 1521-6934            Impact factor:   5.237


  14 in total

Review 1.  Polycystic ovary syndrome throughout a woman's life.

Authors:  José Bellver; Luis Rodríguez-Tabernero; Ana Robles; Elkin Muñoz; Francisca Martínez; José Landeras; Juan García-Velasco; Juan Fontes; Mónica Álvarez; Claudio Álvarez; Belén Acevedo
Journal:  J Assist Reprod Genet       Date:  2017-09-27       Impact factor: 3.412

2.  Impact of cancer treatment on risk of infertility and diminished ovarian reserve in women with polycystic ovary syndrome.

Authors:  Lisa M Shandley; Amy Fothergill; Jessica B Spencer; Ann C Mertens; Hanh N Cottrell; Penelope P Howards
Journal:  Fertil Steril       Date:  2018-02-07       Impact factor: 7.329

3.  A Polygenic and Phenotypic Risk Prediction for Polycystic Ovary Syndrome Evaluated by Phenome-Wide Association Studies.

Authors:  Yoonjung Yoonie Joo; Ky'Era Actkins; Jennifer A Pacheco; Anna O Basile; Robert Carroll; David R Crosslin; Felix Day; Joshua C Denny; Digna R Velez Edwards; Hakon Hakonarson; John B Harley; Scott J Hebbring; Kevin Ho; Gail P Jarvik; Michelle Jones; Tugce Karaderi; Frank D Mentch; Cindy Meun; Bahram Namjou; Sarah Pendergrass; Marylyn D Ritchie; Ian B Stanaway; Margrit Urbanek; Theresa L Walunas; Maureen Smith; Rex L Chisholm; Abel N Kho; Lea Davis; M Geoffrey Hayes
Journal:  J Clin Endocrinol Metab       Date:  2020-06-01       Impact factor: 5.958

4.  Association between an AMH promoter polymorphism and serum AMH levels in PCOS patients.

Authors:  Loes M E Moolhuijsen; Yvonne V Louwers; Anke McLuskey; Linda Broer; Andre G Uitterlinden; Renée M G Verdiesen; Ryan K Sisk; Andrea Dunaif; Joop S E Laven; Jenny A Visser
Journal:  Hum Reprod       Date:  2022-06-30       Impact factor: 6.353

Review 5.  Inflammation and reproductive function in women with polycystic ovary syndrome†.

Authors:  Leandro M Velez; Marcus Seldin; Alicia B Motta
Journal:  Biol Reprod       Date:  2021-06-04       Impact factor: 4.285

6.  Recurrent maternal virilization during pregnancy in patients with PCOS: two clinical cases.

Authors:  M Deknuydt; A Dumont; A Bruyneel; D Dewailly; S Catteau-Jonard
Journal:  Reprod Biol Endocrinol       Date:  2018-10-30       Impact factor: 5.211

7.  The effects of exercise on cardiometabolic outcomes in women with polycystic ovary syndrome not taking the oral contraceptive pill: protocol for a systematic review and meta-analysis.

Authors:  Amie Woodward; Markos Klonizakis; Ian Lahart; Anouska Carter; Caroline Dalton; Mostafa Metwally; David Broom
Journal:  Syst Rev       Date:  2019-05-16

Review 8.  Hyperprolactinemia, Clinical Considerations, and Infertility in Women on Antipsychotic Medications.

Authors:  Amber N Edinoff; Nancy S Silverblatt; Hayley E Vervaeke; Cassidy C Horton; Eden Girma; Alan D Kaye; Adam Kaye; Jessica S Kaye; Andrew J Garcia; Elisa E Neuchat; Treniece N Eubanks; Giustino Varrassi; Omar Viswanath; Ivan Urits
Journal:  Psychopharmacol Bull       Date:  2021-03-16

9.  2D and 3D Trans-vaginal Sonography to Determine Cut-offs for Ovarian Volume and Follicle Number per Ovary for Diagnosis of Polycystic Ovary Syndrome in Indian Women.

Authors:  Kar Sujata; Samparna Swoyam
Journal:  J Reprod Infertil       Date:  2018 Jul-Sep

10.  Supervised exercise training and increased physical activity to reduce cardiovascular disease risk in women with polycystic ovary syndrome: study protocol for a randomized controlled feasibility trial.

Authors:  Amie Woodward; David Broom; Caroline Dalton; Mostafa Metwally; Markos Klonizakis
Journal:  Trials       Date:  2020-01-20       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.